Indication

Alopecia areata

Alopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults. Read more about Alopecia areata

11 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Alopecia areata therapies.

Showing 1–9 of 11 drugs

Filter & compare in the drug finder →Opens the drug finder with Alopecia areata preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Alopecia areata.

Alopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults.

Pathophysiologically, it is driven by a breakdown of hair follicle immune privilege, leading to lymphocytic infiltration around anagen hair bulbs, follicular disruption, and premature transition into the telogen phase while sparing the follicular stem cells.

Clinically, it most often manifests as smooth, sharply demarcated, round or oval patches of sudden hair loss primarily on the scalp, accompanied by trichoscopic findings such as exclamation point hairs and occasional nail dystrophy.

Although the course is often relapsing and remitting, severe presentations may progress to the total loss of scalp hair or complete body hair loss.

Personalize your experience

Follow Alopecia areata and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it